Literature DB >> 28208938

Institutional Experience in the Management of Hilar Liver Obstruction- A Series of 13 Cases.

Adithya Malolan Pathanki1, Adithya V Naragund2, Basant Mahadevappa3.   

Abstract

Neoplastic hilar obstruction to the liver outflow presents a unique challenge to the surgeon, wherein, the balance between a curative and possibly larger resection has to be achieved against a more conservative local resection. These are often technically demanding and have thus, far produced equivocal outcomes on both ends. The present case series is on 13 patients who presented with hilar obstruction. They all underwent resections with possible curative intent. The focus of our review is on the technical nuances and the strategies we used, intra- and peri-operatively to make resections possible in these patients, who at first look were deemed inoperable. Among the 13, 10 had hilar cholangiocarcinoma (CCA) while the others had a more benign diagnosis e.g., Hydatid disease. We did not encounter any peri-operative mortality in our series. Two of our patients had to be re-explored for intra-abdominal complications. Among the 13, we encountered two deaths. The rest of the patients are still on follow-up as of April 2016. Hilar CCA continue to be rare and challenging tumours for the Hepato Pancreato Biliary (HPB) surgeon to manage. Outlooks are currently changing as we try to resect bigger and more complicated hilar liver tumours with better results.

Entities:  

Keywords:  Biliary stenting; Hepaticojejunostomy; Major Hepatectomy

Year:  2016        PMID: 28208938      PMCID: PMC5296511          DOI: 10.7860/JCDR/2016/20564.8989

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  18 in total

Review 1.  Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  A T Ruys; B E van Beem; M R W Engelbrecht; S Bipat; J Stoker; T M Van Gulik
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

2.  Direct visualization of indeterminate pancreaticobiliary strictures with probe-based confocal laser endomicroscopy: a multicenter experience.

Authors:  Alexander Meining; Yang K Chen; Douglas Pleskow; Peter Stevens; Raj J Shah; Ram Chuttani; Joel Michalek; Adam Slivka
Journal:  Gastrointest Endosc       Date:  2011-07-29       Impact factor: 9.427

3.  Incidence of benign lesions in patients resected for suspicious hilar obstruction.

Authors:  M F Gerhards; P Vos; T M van Gulik; E A Rauws; A Bosma; D J Gouma
Journal:  Br J Surg       Date:  2001-01       Impact factor: 6.939

4.  Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.

Authors:  Peter Neuhaus; Armin Thelen; Sven Jonas; Gero Puhl; Timm Denecke; Wilfried Veltzke-Schlieker; Daniel Seehofer
Journal:  Ann Surg Oncol       Date:  2011-10-01       Impact factor: 5.344

5.  Liver Hydatid Cyst and Acute Cholangitis: a Case Report.

Authors:  Behzad Nemati Honar; Gholamhossein Hayatollah; Mohammadreza Nikshoar; Mojgan Forootan; Ali Mohammad Feizi
Journal:  Acta Med Iran       Date:  2016-04

6.  Drainage-related Complications in Percutaneous Transhepatic Biliary Drainage: An Analysis Over 10 Years.

Authors:  Simon Nennstiel; Andreas Weber; Günter Frick; Bernhard Haller; Alexander Meining; Roland M Schmid; Bruno Neu
Journal:  J Clin Gastroenterol       Date:  2015-10       Impact factor: 3.062

7.  Differential diagnosis of stenosing lesions at the hepatic hilus.

Authors:  Jonathan Koea; Andrew Holden; Kai Chau; John McCall
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

8.  Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors.

Authors:  P C Verbeek; D J van Leeuwen; L T de Wit; J W Reeders; N J Smits; A Bosma; K Huibregtse; M N van der Heyde
Journal:  Surgery       Date:  1992-11       Impact factor: 3.982

9.  Endoscopic or percutaneous biliary drainage for Klatskin tumors?

Authors:  Thomas Walter; Chia S Ho; Anne M Horgan; Andrew Warkentin; Steve Gallinger; Paul D Greig; Paul Kortan; Jennifer J Knox
Journal:  J Vasc Interv Radiol       Date:  2012-11-22       Impact factor: 3.464

10.  Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases.

Authors:  Kawin Leelawat; Siriluck Narong; Jerasak Wannaprasert; Surang Leelawat
Journal:  Int J Hepatol       Date:  2010-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.